Salute e Benessere

Implantica presents the second quarter 2023 on August 24 at 15:00 CET

If you wish to participate via webcast, please use the following link: If you wish to participate via webcast, please use the following link: If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the conference. Speakers: For further information, please contact: Nicole Pehrsson, Investor Relations Telephone (CH): +41 (0)79 335 09 49nicole.pehrsson@implantica...
PR Newswire
18/08/2023

NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2023 (UNAUDITED)

Company announcement , Helsinki, 18 August 2023, at 9 am (EEST)NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30,2023 (UNAUDITED) IN THE FIRST HALF OF THE YEAR, THE COMPANY FOCUSED ON COST EFFICIENCYThe figures in parentheses refer to the previous year's comparative period, unless otherwise stated. January–June 2023 in briefThe company's net sales were EUR 2.5 million (6.8, comparative 3.3), with a decrease of 63.1 %. Net sales of the comparative...
Nasdaq GlobeNewswire
18/08/2023

Novartis issues EGM Invitation and Shareholder Information Brochure. Sandoz…

Ad hoc announcement pursuant to Art. 53 LR Invitation to Novartis Extraordinary General Meeting on September 15, 2023, and Shareholder Information Brochure issuedSandoz Listing Prospectus publishedProposed distribution of a dividend-in-kind of Sandoz shares to Novartis shareholders: one Sandoz share for every five Novartis shares and one Sandoz ADR for every five Novartis ADRsSandoz Spin-off planned to occur on or around October 4, 2023 Basel, August 18, 2023—...
Nasdaq GlobeNewswire
18/08/2023

Nerve Repair and Regeneration Global Market is Expected to Showcase a…

Key Takeaways from the Nerve Repair and Regeneration Market Report Key Takeaways from the Nerve Repair and Regeneration Market Report To read more about the latest highlights related to the nerve repair and regeneration market, get a snapshot of the key highlights entailed in theGlobal Nerve Repair and Regeneration Market Report Nerve Repair and Regeneration Overview Nerve repair and regeneration is a complex and fascinating field within the realm of medical science...
PR Newswire
17/08/2023

India's G20 Presidency Drives Global Digital Health Initiative for Accessible…

Further exemplifying the G20's holistic approach is the upcoming Joint Health and Finance Track meeting on August 19. While the permanent Global Medical Countermeasures Mechanism is being finalised under the INB process expected to conclude in May 2024, India's G20 Presidency brought into focus the need for such a platform to deliver safe, quality and effective medical countermeasures to ensure accessibility, availability, and affordability of medical countermeasures. Further exemplifying the...
PR Newswire
17/08/2023

The Medical Drones Market is projected to be close to USD 3 billion by 2035…

Over the years, drones have become indispensable in healthcare, delivering drugs, medical kits, vaccines, organs, and surgical equipment. They are designed to transport the medical resources swiftly and safely to remote or hard-to-reach areas, especially in emergency situations where timely delivery is critical. Further, the incorporation of modern technologies, such as artificial intelligence (AI), machine learning (ML), and computer vision (CV), has made drones smarter and more efficient. As…
PR Newswire
17/08/2023

Coloplast Finance B.V. - Announcement no. 04/2023 - Interim Financial Report 9M…

9M 2022/23 Interim financial results, 9M 2022/231 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin 1). Reported revenue in DKK grew 4% to 6,108 millionOrganic growth rates by business area: Ostomy Care 8%, Continence Care 9%, Voice and Respiratory Care 9%, Wound and Skin Care 4% (Wound Care 5%), and Interventional Urology 7%.Continued good momentum across regions in Chronic Care. China Ostomy Care posted double-digit growth, reflecting a...
Nasdaq GlobeNewswire
17/08/2023

Immatics Announces Second Quarter 2023 Financial Results and Business Update

Phase 1/2 clinical trial initiated evaluating Immatics' second next-generation half-life extended TCR Bispecific program, TCER® IMA402 targeting PRAMEACTengine® IMA203 TCR-T monotherapy against PRAME showed 67% confirmed ORR in an interim clinical update on 11 heavily pre-treated patients in Phase 1b dose expansion Cohort A with median duration of response not reached at a median follow-up time of 8.5 months at data cut-off; next update in 4Q 2023Bristol Myers Squibb exercised first...
Nasdaq GlobeNewswire
17/08/2023

Tiziana Life Sciences Announces Live Bloomberg TV Interview of Renowned…

TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announced that Dr. Howard L. Weiner, a thought leader in the field of neurology and immunology, was featured in an exclusive live interview on Bloomberg to discuss the Company's latest announcement on its advancement of the novel foralumab program in Alzheimer's disease following recent U.S. Food and Drug Administration (FDA)...
Nasdaq GlobeNewswire
17/08/2023

Cold Chain Monitoring Market to be Worth $119.74 Billion by 2030: Grand View…

Read full market research report, "Cold Chain Monitoring Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Application (Food & Beverages, Pharmaceuticals), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report, " Cold Chain Monitoring Market Size, Share & Trends Analysis Report By Component (Hardware, Software), By Application (Food & Beverages, Pharmaceuticals), By Region…
PR Newswire
17/08/2023

Conversion of convertible notes pursuant to financing arrangement between…

BBS-Bioactive Bone Substitutes Plc, Company announcement, 17 August 2023 at 12:00 p.m. Conversion of convertible notes pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and Riverfort Global Opportunities PCC LtdBBS-Bioactive Bone Substitutes Plc (“BBS” or the "Company") has received a request by Riverfort Global Opportunities PCC Ltd to convert a proportion of EUR 50,000 of the convertible notes into Company shares at a conversion price of EUR 0.39483 per...
Nasdaq GlobeNewswire
17/08/2023

Major shareholder announcement

ANNOUNCEMENT NO. 23917 August 2023Major shareholder announcementMajor shareholder announcement–BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock, Inc. has increased its aggregate holding of shares and financial instruments in ChemoMetec A/S to 5.02% of the share capital and voting rights, and that the shareholding thus exceeds the 5 per cent limit in...
Nasdaq GlobeNewswire
17/08/2023

LOST MARY in a global move against counterfeits

"Ever since LOST MARY's inception, our labeled quality products have gained a huge global user base with increasing recognition. However, counterfeit manufacturers also followed suit and became rampant in copying some of our key LOST MARY-branded elements when cloning our products," said a LOST MARY spokesperson. "Ever since LOST MARY's inception, our labeled quality products have gained a huge global user base with increasing recognition. However, counterfeit manufacturers also…
PR Newswire
17/08/2023

Emerging Technologies Drive Growth in the Organ Preservation Market, According…

In this report, Dr. Achla, BDS and health science analyst at BCC Research delves into an analysis of the prospective advancements in medical technologies. It sheds light on the evolving landscape of Static Cold Storage, hypothermic machine perfusion, and normothermic machine perfusion while providing market projections on instruments, solutions, and disposables. Additionally, the report explores global organ donation policies, examining the ethical and social dimensions underpinning these…
PR Newswire
17/08/2023

Medical Rehabilitation Services Market to Reach $305.7 Billion, Globally, by…

Request Sample of the Report on Medical Rehabilitation Services Market Forecast 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/111281 Request Sample of the Report on Medical Rehabilitation Services Market Forecast 2032- Allied Market Research-https://www.alliedmarketresearch.com/request-sample/111281 Medical rehabilitation services refer to a range of healthcare aids and therapies aimed at regaining, improving, or maintaining the physical,...
PR Newswire
17/08/2023

Foulath Subsidiary, Bahrain Steel, Signs LOI for Iron Ore Pellet Supply to Essar…

Commenting on the partnership, Mr. Dilip George, Group CEO of Foulath Holding, said: "Bahrain Steel's LOI with Essar for the supply of 4 million tonnes of DR grade pellets annually is a testament to our commitment to meet the growing demand for DR pellets by the steel industry in the GCC. We are proud to collaborate with Essar Group to support their pioneering project for setting up the first green steel project in Saudi Arabia, where there is a growing focus on sustainable…
PR Newswire
17/08/2023

Newpark Healthcare Advances Operational Efficiency with IntelliTek Health's…

"This is like having 'Control F' across your entire organization, being able to locate crucial documents and information within seconds from any repository the tool can access," added "Carmel Roberts" SSME Quality and Patient Safety. "This is like having 'Control F' across your entire organization, being able to locate crucial documents and information within seconds from any repository the tool can access," added "Carmel Roberts" SSME Quality and Patient…
PR Newswire
17/08/2023

Interim Report Q2, 2023: Calliditas Therapeutics

FINANCIAL SUMMARY FOR THE GROUP FINANCIAL SUMMARY FOR THE GROUP Key Figures April 1 - June 30, 2023 January 1 - June 30, 2023 Significant Events in Q2 2023, in Summary Key Takeaways: Updated 2023 Outlook For 2023, Calliditas expects revenue growth in the US where: Net sales from TARPEYO are estimated to beUSD 100 -120 million for the year endingDecember 31, 2023. Investor PresentationAugust 17, 2023,14:30 CET Audio cast with teleconference,...
PR Newswire
17/08/2023

Coloplast A/S - Announcement no. 04/2023 - Interim Financial Report, 9M…

9M 2022/23 Interim financial results, 9M 2022/231 October 2022 - 30 June 2023 Coloplast delivered Q3 organic growth of 8% and 28% EBIT margin 1). Reported revenue in DKK grew 4% to 6,108 millionOrganic growth rates by business area: Ostomy Care 8%, Continence Care 9%, Voice and Respiratory Care 9%, Wound and Skin Care 4% (Wound Care 5%), and Interventional Urology 7%.Continued good momentum across regions in Chronic Care. China Ostomy Care posted double-digit growth, reflecting a...
Nasdaq GlobeNewswire
17/08/2023

Valneva Announces Extension of Existing Loan Agreement

Up to an additional $100 million made available in two tranchesSaint-Herblain(France), August 17 , 2023–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an agreement to increase the principal amount of its existing $100 million senior secured debt financing agreement with funds managed by leading U.S. healthcare investment firms Deerfield Management Company and OrbiMed. The add-on loan facility provides Valneva with...
Nasdaq GlobeNewswire
17/08/2023

Zealand Pharma Announces Financial Results for the First Half of 2023

Company announcement - No. 28 / 2023 Zealand Pharma Announces Financial Results for the First Half of 2023Strong progress across R&D pipeline and significant strengthening of the balance sheetBoehringer Ingelheim to move into Phase 3 trials with GCGR/GLP-1R dual agonist survodutide (BI456906) in obesity following positive Phase 2 dataEncouraging weight loss and tolerability data from long-acting amylin analog ZP8396Regulatory submission of NDA to the US FDA for dasiglucagon...
Nasdaq GlobeNewswire
17/08/2023

Unispace Group strengthens its life sciences offering by acquiring Bulb

Bulb designs and builds inspiring working environments in the life sciences sector, including R&D facilities, high-tech laboratory spaces, production facilities, and corporate offices. Bulb operates across the UK and has delivered complex projects for clients, including Kadans Science Partners and Advanced Research Clusters (ARC). Bulb designs and builds inspiring working environments in the life sciences sector, including R&D facilities, high-tech laboratory spaces, production…
PR Newswire
17/08/2023

Roche launches a new addition to the cobas® connection modules, the CCM…

"Given the dynamic requirements of the healthcare system, laboratories and clinicians are expected to optimise laboratory operations and efficiencies while improving patient care," said Ann Costello, Head of Roche Diagnostics Solutions at Roche Diagnostics. "We are excited about CCM Vertical, it simplifies and streamlines testing for laboratories of all sizes, throughputs and disciplines, while supporting clinical decision-making to improve patient care." "Given the…
PR Newswire
17/08/2023

Tigermed Officially Opens International Headquarters in Hong Kong

Tigermed established its Hong Kong office in 2011 and has partnered with local researchers and clinical sites for over a decade to advance various innovative product development. In August 2020, Tigermed was listed on the Hong Kong Stock Exchange (HKSE), marking the landing of the company's "A + H" dual-capital platform. The opening of Tigermed International Headquarters in Hong Kong demonstrated its strong commitment to expanding research capability and global reach to build a…
PR Newswire
17/08/2023
Altri  Comunicati